Because the cancer relies on estrogen for growth, patients with an ICD-10 diagnosis reflecting ER+ status are candidates for therapies such as tamoxifen or aromatase inhibitors. Furthermore, the system requires differentiation between the right breast, left breast, and bilateral instances, ensuring precise mapping of the disease location for comprehensive patient records and statistical analysis.
ICD 10 Unspecified Side ER Positive Breast Cancer Coding and Treatment Implications
Tracking the incidence of C50. Accurate coding using the ICD-10 system is essential for treatment planning, insurance reimbursement, and epidemiological research, making the correct identification of this subtype critical for both clinicians and patients.
Laterality Extension: Characters 4 and 5 specify the side (1=right, 2=left, 3=bilateral, 4=unspecified). Data, Research, and Public Health On a population level, the specificity of the ICD-10 coding for estrogen receptor status provides invaluable data for public health officials and researchers.
ICD 10 Unspecified Side ER Positive Breast Cancer Coding and Treatment Implications
The determination of receptor status is typically performed through immunohistochemistry (IHC) on a biopsy sample, providing a definitive classification that guides the entire therapeutic strategy. ICD-10 Coding Specifics and Range While the general code for malignant neoplasm of the breast is C50, the ICD-10 system allows for significant specificity regarding the hormonal status of the tumor.
More About Estrogen receptor positive breast cancer icd 10
Looking at Estrogen receptor positive breast cancer icd 10 from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Estrogen receptor positive breast cancer icd 10 can make the topic easier to follow by connecting earlier points with a few simple takeaways.
